News

UK MHRA grants marketing authorisation to Biogen’s omaveloxolone to treat Friedreich’s ataxia: United Kingdom Friday, April 25, 2025, 12:00 Hrs [IST] The Medicines and Healthc ...
Gujarat FDCA trains 900 MSMEs to submit gap analysis documentation as per revised Schedule M: Shardul Nautiyal, Mumbai Friday ...
Increases in vaccine-preventable disease outbreaks threaten years of progress, warn WHO, UNICEF & Gavi: Geneva, Switzerland Friday, April 25, 2025, 11:00 Hrs [IST] Immunization ef ...
Pfizer advances bold vision for future of cancer care at the ASCO 2025 annual meeting: New York Friday, April 25, 2025, 10:00 Hrs [IST] Pfizer Inc. will showcase data across its p ...
Daiichi Sankyo seeks Japanese approval for Enhertu to treat patients with HER2 positive metastatic solid tumours: Tokyo Friday, April 25, 2025, 09:00 Hrs [IST] Daiichi Sankyo has ...
Indian pharma researchers are now focusing on monoclonal antibodies to treat malaria: Nandita Vijaysimha, Bengaluru Friday, April 25, 2025, 08:00 Hrs [IST] Indian pharma researche ...
MSMEs poised to capture global generics & biosimilars markets through collaborative efforts: FPME: Shardul Nautiyal, Mumbai Friday, April 25, 2025, 08:00 Hrs [IST] Amid evolving g ...
Panel recommends NCH to assess efficacy of Homoeopathy to increase faith among public: Gireesh Babu, New Delhi Friday, April 25, 2025, 08:00 Hrs [IST] The Parliamentary Panel on H ...
IPA demands representation in Curriculum Drafting Committee for B Pharm: Peethaambaran Kunnathoor, Chennai Friday, April 25, 2025, 08:00 Hrs [IST] Appreciating the efforts of the ...
AP Biosciences doses first patient in phase 1 clinical study to evaluate AP402 for HER2+ cancer patients: Taipei City, Taiwan Thursday, April 24, 2025, 18:00 Hrs [IST] AP Bioscien ...
Syngene’s revenue from operations crossed Rs. 1,000 crore mark in Q4, PAT dips by 3%, full year earnings up 4% to Rs. 3,642 crore: Our Bureau, Bengaluru Thursday, April 24, 2025 ...